SCHEMBL4911900

SCHEMBL4911900

CC(C)(O)[C@@H]1CCC[C@H]1C(=O)c1ncc(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)s1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 4/20 0.57
KDR P35968 10/20 0.47
PDGFRB P09619 4/20 0.47
FLT3 P36888 4/20 0.47
KIT P10721 4/20 0.47
FLT1 P17948 4/20 0.47
LCK P06239 3/20 0.47
CSF1R P07333 3/20 0.47
FGFR1 P11362 3/20 0.47
FGFR3 P22607 3/20 0.47
FLT4 P35916 3/20 0.47
TEK Q02763 2/20 0.47
PDGFRA P16234 1/20 0.47
FGFR2 P21802 1/20 0.47
FGFR4 P22455 1/20 0.47
RIPK1 Q13546 1/20 0.46
RET P07949 3/20 0.46
AURKB Q96GD4 3/20 0.46
NTRK1 P04629 3/20 0.46
NTRK2 Q16620 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4911897 1.00 DGAT1 (0.57) DGAT1KDRPDGFRBFLT3KIT
SCHEMBL4924031 1.00 DGAT1 (0.57) DGAT1KDRPDGFRBFLT3KIT
SCHEMBL4924491 0.89 DGAT1 (0.72) DGAT1KDRPDGFRBFLT3KIT
SCHEMBL4924477 0.89 DGAT1 (0.72) DGAT1KDRPDGFRBFLT3KIT
SCHEMBL4924483 0.89 DGAT1 (0.72) DGAT1KDRPDGFRBFLT3KIT
SCHEMBL4923400 0.86 DGAT1 (0.66) DGAT1KDRPDGFRBFLT3KIT
SCHEMBL4923402 0.82 DGAT1 (0.51) DGAT1KDRPDGFRBFLT3KIT
SCHEMBL4922391 0.82 DGAT1 (0.63) DGAT1KDRBRAF
SCHEMBL4922387 0.82 DGAT1 (0.63) DGAT1KDRBRAF
SCHEMBL4922382 0.82 DGAT1 (0.63) DGAT1KDRBRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080064717-A1 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme ABBOTT LABORATORIES 2008-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064717-A1 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme DGAT1, DGAT2, DLAT DGAT1 1/4885KDR 4607/4885PDGFRB 3310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.